Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. ESMO Videos
  3. Gastrointestinal Cancer Videos

Sotorasib, Panitumumab and FOLFIRI in the First-Line Setting for KRAS G12C–mutated mCRC

Breaking Science in Gastrointestinal Cancer Video Series

Login to get immediate access to this content.

Login

Speaker: Salvatore Siena, Italy

Abstract discussed:

  • 505O - Sotorasib (soto), panitumumab (pani) and FOLFIRI in the first-line (1L) setting for KRAS G12C–mutated metastatic colorectal cancer (mCRC): Safety and efficacy analysis from the phase 1b CodeBreaK 101 study: Watch the presentation from ESMO 2024 now

The speakers and studies featured in this video series were selected independently by ESMO.

Published October 2024

Related Videos

Screenshot Christelle DE LA FOUCHARDIERE
Screenshot David TOUGERON
Screenshot Peter DE GOOYER
Screenshot Yelena JANJIGIAN

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.